Aldeyra Therapeutics, Inc.
ALDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $297 | $207 | $407 | $216 |
| - Cash | $55 | $143 | $144 | $230 |
| + Debt | $15 | $16 | $16 | $16 |
| Enterprise Value | $258 | $80 | $278 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$54 | -$35 | -$60 | -$56 |
| % Margin | – | – | – | – |
| Net Income | -$56 | -$38 | -$62 | -$58 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.94 | -0.64 | -1.06 | -1.07 |
| % Growth | -46.9% | 39.6% | 0.9% | – |
| Operating Cash Flow | -$43 | -$30 | -$57 | -$43 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$43 | -$30 | -$57 | -$43 |